Programming - EPI|Lifestyle
The EPI|Lifestyle 2021 Scientific Sessions virtual meeting will be held Thursday and Friday, May 20–21, 2021.
This year's conference will focus on health equity and social justice with our keynote sessions highlighting equity and COVID-19, presentation of the latest science on a variety of topics, and a robust virtual networking experience. Download the full program details (PDF).
EPI/Lifestyle Program Information
The primary goal of EPI/Lifestyle 2021 Scientific Sessions is to promote the development and application of translational and population science to prevent heart disease and stroke and foster cardiovascular health. The Councils on Epidemiology and Prevention (EPI) and Lifestyle and Cardiometabolic Health (Lifestyle) jointly planned the EPI/Lifestyle 2021 Scientific Sessions. The sessions focus on risk factors, obesity, nutrition, physical activity, genetics, metabolism, biomarkers, subclinical disease, clinical disease, healthy populations, global health, and prevention-oriented clinical trials.
The program is designed to present new findings on:
- Cardiovascular disease prevention trials
- Causes and mechanisms of health factors, subclinical, and clinical cardiovascular diseases
- Relationships of nutrition (diet) and physical activity (fitness) with cardiometabolic health
- Relationships of obesity, diabetes, and renal disease with cardiometabolic health
- Genetic and environmental epidemiology of cardiometabolic health
- Effects of lifestyle interventions on cardiometabolic disease and its health factors
- Population trends in cardiovascular diseases and their health factors
- Global cardiovascular health
The program also will provide participants with the opportunity to learn current information about:
- Advances in measuring diet and physical activity
- Advances in techniques in preventive cardiology
- Behavioral strategies to promote and sustain lifestyle modifications
- Outcomes research and guideline development related to cardiovascular health
- Advances in methods relevant to observational studies, clinical trials and population surveillance
The program includes presentations of new high-quality, high-impact research, organized around oral, moderated poster, and poster abstract presentations. Special translational science lectures and debates address current issues relevant to cardiometabolic health and preventive cardiology. This format maximizes the opportunities for thought-provoking multidisciplinary interactions across a wide spectrum of scientists, junior and established. The sessions are designed to enhance the careers of young and early mid-career investigators and practitioners committed to the promotion of cardiometabolic health.
The conference is designed to benefit researchers as well as public health practitioners and clinicians. The meeting should appeal to physicians, epidemiologists, dietitians, nutritional scientists, exercise physiologists, behavioral scientists, biostatisticians, pharmacists, physician assistants, nurses, school health professionals and other health scientists.
- Recognize opportunities to address identifiable and modifiable risk factors for ASCVD and implement the recommendations from recent guidelines on primary ASCVD prevention as well as tobacco use.
- Analyze the causes and health consequences of continuing disparities in ASCVD risk factors among certain racial/ethnic, gender and socioeconomic groups.
- Describe the relationship between psychological stress and cardiovascular health and evaluate current evidence on psychological interventions to reduce cardiovascular risk.
- Describe the impact of the built environment on the cardiovascular health of populations and identify research and preventative opportunities to improve such environments.
- Discuss current evidence and research needs related to primordial and primary ASCVD prevention in children and adolescents.
- Explain the concepts of Big Data and precision medicine and identify research opportunities as well as their applications in ASCVD prevention and treatment.
- Identify innovative areas and new skillsets for research in cardiovascular epidemiology for early-career scientists as well as the existing scientific workforce.